Oral LD50 of standardized extract in mice is 7730 mg/kg, which corresponds to 2300 mg/kg of active ingredients, 1900 mg/kg of flavone glycosides, and 464 mg/kg of terpene lactones. Intravenous LD50 is 1100 mg/kg.L32779
No case of overdose has been reported so far.L10247 Cyanogenic glycosides found in raw ginkgo seeds are potentially toxic compounds; thus, contact or ingestion of ginkgo seeds can lead to serious reactions such as allergic skin reaction, including acute generalized exanthematous pustulosis, and convulsions. Ginkgo toxicity can manifest as bleeding, seizure, and serotonin syndrome. As there is no known antidote for ginkgo toxicity, treatment includes discontinuation of ginkgo and symptomatic and supportive care.A232379 Seizures may be attributed to ginkgotoxin, which can cause seizures at high doses.L32798
Ginkgo biloba extract contains a group of terpene lactones (notably, ginkgolides and diterpenes) and ginkgo flavone glycosides (notably, ginkgetin, bilobetin, and sciadopitysin) that have antioxidant and vasoactive properties.A232389 Most of the studies that investigate the effect of ginkgo biloba use the standardized extract of Ginkgo biloba (EGb) 761 (EGb761), which was developed by a German pharmaceutical company in 1964.A232404 EGb761 contains 6% terpene lactones and 24% flavonoid glycosides.A232379 Flavonoids include quercetin, rutin, kaempferol, and isorhamnetin. Lactones include ginkgolide A, ginkgolide B, ginkgolide C, bilobalide, and ginkgotoxin, a lactone that is structurally related to pyridoxine.L32789 Ginkgo biloba is an herbal plant that is now cultivated worldwide. It is originally native to China, and ginkgo biloba extract has been used in traditional Chinese medicine for centuries.A232389
After its nootropic properties were discovered, ginkgo biloba has gained attention as a therapeutic ingredient for memory and concentration enhancement in cognitive impairment and neurogenerative diseases, such as dementia.A232384 Ginkgo biloba was investigated in preliminary studies for a variety of therapeutic purposes such as improving cardiovascular health, sexual dysfunction, psychiatric disorders, skin disorders, and glaucoma. Ginkgo biloba is found in a number of homeopathic and over-the-counter herbal products and dietary supplements, but it has no approved therapeutic indications by regulatory bodies, such as the FDA, EMA, and Health Canada.A232379 Ginkgo folium, the leaf extract of Ginkgo biloba, is considered an anti-dementia drug by the World Health Organization.A232389
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Lomitapide | The metabolism of Lomitapide can be decreased when combined with Ginkgo biloba. |
| Aminosalicylic acid | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Aminosalicylic acid. |
| Mesalazine | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Mesalazine. |
| Sulfasalazine | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Sulfasalazine. |
| Diflunisal | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Diflunisal. |
| Salicylic acid | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Salicylic acid. |
| Balsalazide | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Balsalazide. |
| Olsalazine | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Olsalazine. |
| Bismuth subsalicylate | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Bismuth subsalicylate. |
| Dersalazine | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Dersalazine. |
| Phenyl aminosalicylate | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Phenyl aminosalicylate. |
| Methyl salicylate | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Methyl salicylate. |
| Nitroaspirin | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Nitroaspirin. |
| Aloxiprin | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Aloxiprin. |
| Guacetisal | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Guacetisal. |
| Carbaspirin calcium | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Carbaspirin calcium. |
| Choline salicylate | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Choline salicylate. |
| Thiosalicylic acid | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Thiosalicylic acid. |
| Acetylsalicylic acid | The risk or severity of bleeding can be increased when Ginkgo biloba is combined with Acetylsalicylic acid. |
| Dipyridamole | The therapeutic efficacy of Ginkgo biloba can be decreased when used in combination with Dipyridamole. |
| Ephedrine | Ginkgo biloba may increase the neuromuscular blocking activities of Ephedrine. |
| Bambuterol | Ginkgo biloba may increase the neuromuscular blocking activities of Bambuterol. |
| Clevidipine | Ginkgo biloba may increase the neuromuscular blocking activities of Clevidipine. |
| Sar9, Met (O2)11-Substance P | Ginkgo biloba may increase the neuromuscular blocking activities of Sar9, Met (O2)11-Substance P. |
| Mirabegron | Ginkgo biloba may increase the neuromuscular blocking activities of Mirabegron. |
| Moxisylyte | Ginkgo biloba may increase the neuromuscular blocking activities of Moxisylyte. |
| Procaine | Ginkgo biloba may increase the neuromuscular blocking activities of Procaine. |
| Cocaine | Ginkgo biloba may increase the neuromuscular blocking activities of Cocaine. |
| Trimethaphan | Ginkgo biloba may increase the neuromuscular blocking activities of Trimethaphan. |
| Doxacurium | Ginkgo biloba may increase the neuromuscular blocking activities of Doxacurium. |
| Chloroprocaine | Ginkgo biloba may increase the neuromuscular blocking activities of Chloroprocaine. |
| Tubocurarine | Ginkgo biloba may increase the neuromuscular blocking activities of Tubocurarine. |
| Aclidinium | Ginkgo biloba may increase the neuromuscular blocking activities of Aclidinium. |
| Butyrylthiocholine | Ginkgo biloba may increase the neuromuscular blocking activities of Butyrylthiocholine. |
| Oxybuprocaine | Ginkgo biloba may increase the neuromuscular blocking activities of Oxybuprocaine. |
| Benzonatate | Ginkgo biloba may increase the neuromuscular blocking activities of Benzonatate. |
| Efavirenz | The serum concentration of Efavirenz can be decreased when it is combined with Ginkgo biloba. |
| Lepirudin | Ginkgo biloba may increase the anticoagulant activities of Lepirudin. |
| Bivalirudin | Ginkgo biloba may increase the anticoagulant activities of Bivalirudin. |
| Alteplase | Ginkgo biloba may increase the anticoagulant activities of Alteplase. |
| Urokinase | Ginkgo biloba may increase the anticoagulant activities of Urokinase. |
| Reteplase | Ginkgo biloba may increase the anticoagulant activities of Reteplase. |
| Anistreplase | Ginkgo biloba may increase the anticoagulant activities of Anistreplase. |
| Tenecteplase | Ginkgo biloba may increase the anticoagulant activities of Tenecteplase. |
| Abciximab | Ginkgo biloba may increase the anticoagulant activities of Abciximab. |
| Drotrecogin alfa | Ginkgo biloba may increase the anticoagulant activities of Drotrecogin alfa. |
| Streptokinase | Ginkgo biloba may increase the anticoagulant activities of Streptokinase. |
| Dicoumarol | Ginkgo biloba may increase the anticoagulant activities of Dicoumarol. |
| Argatroban | Ginkgo biloba may increase the anticoagulant activities of Argatroban. |
| Ardeparin | Ginkgo biloba may increase the anticoagulant activities of Ardeparin. |
| Phenindione | Ginkgo biloba may increase the anticoagulant activities of Phenindione. |
| Fondaparinux | Ginkgo biloba may increase the anticoagulant activities of Fondaparinux. |
| Warfarin | Ginkgo biloba may increase the anticoagulant activities of Warfarin. |
| Pentosan polysulfate | Ginkgo biloba may increase the anticoagulant activities of Pentosan polysulfate. |
| Phenprocoumon | Ginkgo biloba may increase the anticoagulant activities of Phenprocoumon. |
| Heparin | Ginkgo biloba may increase the anticoagulant activities of Heparin. |
| Enoxaparin | Ginkgo biloba may increase the anticoagulant activities of Enoxaparin. |
| Epoprostenol | Ginkgo biloba may increase the anticoagulant activities of Epoprostenol. |
| Acenocoumarol | Ginkgo biloba may increase the anticoagulant activities of Acenocoumarol. |
| 4-hydroxycoumarin | Ginkgo biloba may increase the anticoagulant activities of 4-hydroxycoumarin. |
| Coumarin | Ginkgo biloba may increase the anticoagulant activities of Coumarin. |
| Ximelagatran | Ginkgo biloba may increase the anticoagulant activities of Ximelagatran. |
| Desmoteplase | Ginkgo biloba may increase the anticoagulant activities of Desmoteplase. |
| Defibrotide | Ginkgo biloba may increase the anticoagulant activities of Defibrotide. |
| Ancrod | Ginkgo biloba may increase the anticoagulant activities of Ancrod. |
| Beraprost | Ginkgo biloba may increase the anticoagulant activities of Beraprost. |
| Prasugrel | Ginkgo biloba may increase the anticoagulant activities of Prasugrel. |
| Rivaroxaban | Ginkgo biloba may increase the anticoagulant activities of Rivaroxaban. |
| Sulodexide | Ginkgo biloba may increase the anticoagulant activities of Sulodexide. |
| Semuloparin | Ginkgo biloba may increase the anticoagulant activities of Semuloparin. |
| Idraparinux | Ginkgo biloba may increase the anticoagulant activities of Idraparinux. |
| Cangrelor | Ginkgo biloba may increase the anticoagulant activities of Cangrelor. |
| Astaxanthin | Ginkgo biloba may increase the anticoagulant activities of Astaxanthin. |
| Apixaban | Ginkgo biloba may increase the anticoagulant activities of Apixaban. |
| Otamixaban | Ginkgo biloba may increase the anticoagulant activities of Otamixaban. |
| Amediplase | Ginkgo biloba may increase the anticoagulant activities of Amediplase. |
| Dabigatran etexilate | Ginkgo biloba may increase the anticoagulant activities of Dabigatran etexilate. |
| Danaparoid | Ginkgo biloba may increase the anticoagulant activities of Danaparoid. |
| Dalteparin | Ginkgo biloba may increase the anticoagulant activities of Dalteparin. |
| Tinzaparin | Ginkgo biloba may increase the anticoagulant activities of Tinzaparin. |
| (R)-warfarin | Ginkgo biloba may increase the anticoagulant activities of (R)-warfarin. |
| Ethyl biscoumacetate | Ginkgo biloba may increase the anticoagulant activities of Ethyl biscoumacetate. |
| Nadroparin | Ginkgo biloba may increase the anticoagulant activities of Nadroparin. |
| Triflusal | Ginkgo biloba may increase the anticoagulant activities of Triflusal. |
| Ticagrelor | Ginkgo biloba may increase the anticoagulant activities of Ticagrelor. |
| Ditazole | Ginkgo biloba may increase the anticoagulant activities of Ditazole. |
| Vorapaxar | Ginkgo biloba may increase the anticoagulant activities of Vorapaxar. |
| Edoxaban | Ginkgo biloba may increase the anticoagulant activities of Edoxaban. |
| Sodium citrate | Ginkgo biloba may increase the anticoagulant activities of Sodium citrate. |
| Dextran | Ginkgo biloba may increase the anticoagulant activities of Dextran. |
| Bemiparin | Ginkgo biloba may increase the anticoagulant activities of Bemiparin. |
| Parnaparin | Ginkgo biloba may increase the anticoagulant activities of Parnaparin. |
| Desirudin | Ginkgo biloba may increase the anticoagulant activities of Desirudin. |
| Antithrombin Alfa | Ginkgo biloba may increase the anticoagulant activities of Antithrombin Alfa. |
| Protein C | Ginkgo biloba may increase the anticoagulant activities of Protein C. |
| Antithrombin III human | Ginkgo biloba may increase the anticoagulant activities of Antithrombin III human. |
| Letaxaban | Ginkgo biloba may increase the anticoagulant activities of Letaxaban. |
| Darexaban | Ginkgo biloba may increase the anticoagulant activities of Darexaban. |
| Betrixaban | Ginkgo biloba may increase the anticoagulant activities of Betrixaban. |
| Nafamostat | Ginkgo biloba may increase the anticoagulant activities of Nafamostat. |